Latest AI and machine learning research in skin cancer for healthcare professionals.
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies. ...
Oncolytic peptides (OPs) represent a promising class of cancer therapeutics capable of rapidly lysin...
BACKGROUND: Ovarian cancer (OC) is a highly aggressive malignancy with poor prognosis and limited re...
Melanoma is a highly aggressive form of skin cancer with a significant mortality rate. Over the past...
PURPOSE: Oral leukoplakia (OL), the most common oral potentially malignant disorder (OPMD), poses a ...
RNA-based cancer immunotherapy has emerged as a next-generation strategy in oncology, harnessing the...
Lower-grade glioma (LGG) is a highly heterogeneous disease, making accurate prognosis prediction and...
OBJECTIVE: To provide a structured narrative review of current evidence and future directions for ar...
OBJECTIVE: Disulfidptosis is a recently discovered mechanism of cell death caused by disulfide stres...
Triaptosis, an emerging form of cell death, remains poorly characterized in terms of its heterogenei...
INTRODUCTION: Artificial intelligence (AI) is reshaping diagnostic paradigms across oncology. In oph...
Uveal melanoma (UVM) is an aggressive intraocular malignancy with a high risk of metastasis but few ...
Multicellular programs in the tumour microenvironment (TME) drive cancer pathogenesis and response t...
BACKGROUND: Tumour infiltrating lymphocytes (TILs) are a key component of the tumour microenvironmen...
BACKGROUND: Artificial intelligence has significantly advanced computational pathology by enabling h...
Immunotherapy has long played a pivotal role in cancer treatment, and antigen-presenting cell (APC)-...
Immunotherapy has transformed cancer treatment but remains ineffective in many solid tumors, largely...
BACKGROUND: Melanoma represents a highly aggressive and metastatic form of malignant skin cancer. th...
Small cell lung cancer (SCLC) is an aggressive pulmonary neuroendocrine carcinoma characterized by r...
The efficacy of PD-1 inhibitor pucotenlimab (HX008) in solid tumors exhibits heterogeneity. This stu...
BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of h...